Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Zehner

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Nature Protocols|May 26, 2021
Effective high-throughput isolation of fully human antibodies targeting infectious pathogensLutz Gieselmann, Christoph Kreer, Meryem Seda Ercanoglu, et al.
Immunity|May 17, 2015
The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8(+) T cellsMatthias Zehner, Andrea L Marschall, Erik Bos, et al.
Cell Host & Microbe|August 3, 2022
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patternsHenning Gruell, Kanika Vanshylla, Michael Korenkov, et al.
Immunity|November 30, 2023
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variantsMichael Korenkov, Matthias Zehner, Hadas Cohen-Dvashi, et al.
European Journal of Immunology|May 16, 2012
Intraendosomal flow cytometry: a novel approach to analyze the protein composition of antigen-loaded endosomesMatthias Zehner, Judith Rauen, Achmet I Chasan, et al.
Nature Medicine|October 9, 2019
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOVStefanie A Ehrhardt, Matthias Zehner, Verena Krähling, et al.
Iscience|February 28, 2022
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adultsMeryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, et al.
Cell Host & Microbe|May 13, 2021
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humansKanika Vanshylla, Veronica Di Cristanziano, Franziska Kleipass, et al.
Viruses|August 28, 2021
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 InfectionSandro Halwe, Alexandra Kupke, Kanika Vanshylla, et al.
Cell|July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsChristoph Kreer, Matthias Zehner, Timm Weber, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Nature Protocols|May 26, 2021
Effective high-throughput isolation of fully human antibodies targeting infectious pathogensLutz Gieselmann, Christoph Kreer, Meryem Seda Ercanoglu, et al.
Immunity|May 17, 2015
The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8(+) T cellsMatthias Zehner, Andrea L Marschall, Erik Bos, et al.
Cell Host & Microbe|August 3, 2022
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patternsHenning Gruell, Kanika Vanshylla, Michael Korenkov, et al.
Immunity|November 30, 2023
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variantsMichael Korenkov, Matthias Zehner, Hadas Cohen-Dvashi, et al.
European Journal of Immunology|May 16, 2012
Intraendosomal flow cytometry: a novel approach to analyze the protein composition of antigen-loaded endosomesMatthias Zehner, Judith Rauen, Achmet I Chasan, et al.
Nature Medicine|October 9, 2019
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOVStefanie A Ehrhardt, Matthias Zehner, Verena Krähling, et al.
Iscience|February 28, 2022
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adultsMeryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, et al.
Cell Host & Microbe|May 13, 2021
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humansKanika Vanshylla, Veronica Di Cristanziano, Franziska Kleipass, et al.
Viruses|August 28, 2021
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 InfectionSandro Halwe, Alexandra Kupke, Kanika Vanshylla, et al.
Cell|July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsChristoph Kreer, Matthias Zehner, Timm Weber, et al.
Pageof 3